Skip to content

Improving emotion recognition in children with Autism Spectrum Disorders and intellectual disabilities

Improving emotion recognition in children with Autism Spectrum Disorders and Borderline Intellectual Functioning: A Randomized Double-blind Placebo-controlled Intervention Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26856
Enrollment
44
Registered
2014-02-14
Start date
2013-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

* Autism spectrum disorder * ASD * Autism * PDD-NOS * Borderline intellectual functioning * Intellectual disability

Interventions

Two groups of children, randomly assigned to either the treatment condition or placebo group, are compared to each other. The intervention group watches the specifically designed DVD series called 'Th

Sponsors

Karakter Child- and Adolescent Psychiatry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: * Children aged between 6 years, 0 months and 9 years, 11 months - known in psychiatric health care * Children with an Autism Spectrum Disorder, classified by the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). * IQ scores between 70 and 85 ('borderline intellectual functioning') * Access to a PC or TIV with DVD-player * A comorbid ADHD diagnosis is allowed, as long as it is sufficiently treated with medication and dosage is stabile during the intervention.

Exclusion criteria

Exclusion criteria: * Currenlty intensive (ie weekly) individual or group therapy * Diagnosis of one or more of the following comorbid psychiatric disorders: - major depression - psychotic disorder - conduct disorder - attachment disorder - serious moto and/or perceptual disability * Simultaneous participation in another clinical trial * Insufficient motivation for the completing the treatment * Medical illness that needs treatment.

Design outcomes

Primary

MeasureTime frame
Primary outcomes includ neuro-cognitive functioning of the children, social information processing and scores on social behavioral questionnaires. Each of the parameters is assessed at the start of treatment, right after and six months after completing the intervention.

Secondary

MeasureTime frame
Not applicable.

Contacts

Public ContactN. Molendijk

Utrechtseweg 320

n.molendijk@karakter.com0031 26 4002100

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)